Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 45Observational 2Expanded_access 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 2Sarcoma 1Primary Myelofibrosis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Neoplasms 1

Interventions

elotuzumab 4Bortezomib 4Lenalidomide 3Dexamethasone 3talquetamab 2selinexor 2pomalidomide 2carfilzomib 2Panobinostat 2venetoclax 1ulocuplumab 1plerixafor 1idecabtagene vicleucel 1fludarabine phosphate 1daratumumab 1ceritinib 1belantamab mafodotin 1Whole-Body Irradiation 1Tacrolimus 1Prednisone 1Mycophenolic Acid 1Melphalan 1Cytarabine 1Crizotinib 1Cord Blood Stem Cell Transplantation 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × selinexor × Plasma cell × Clear all
NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

Available
GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

NCT03850704 2019-02-22

Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma

Masonic Cancer Center, University of Minnesota

No longer available
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡